BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 28979110)

  • 21. Muscular Dysfunction in COPD: Systemic Effect or Deconditioning?
    Pleguezuelos E; Esquinas C; Moreno E; Guirao L; Ortiz J; Garcia-Alsina J; Merí A; Miravitlles M
    Lung; 2016 Apr; 194(2):249-57. PubMed ID: 26743191
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Systemic inflammatory profile of smokers with and without COPD].
    Mosrane Y; Bougrida M; Alloui AS; Martani M; Rouabah L; Bourahli MK; Mehdioui H; Ben Saad H
    Rev Pneumol Clin; 2017 Sep; 73(4):188-198. PubMed ID: 28838624
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Small airway disease: A different phenotype of early stage COPD associated with biomass smoke exposure.
    Zhao D; Zhou Y; Jiang C; Zhao Z; He F; Ran P
    Respirology; 2018 Feb; 23(2):198-205. PubMed ID: 28906034
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating vascular endothelial growth factor and systemic inflammatory markers in patients with stable and exacerbated chronic obstructive pulmonary disease.
    Valipour A; Schreder M; Wolzt M; Saliba S; Kapiotis S; Eickhoff P; Burghuber OC
    Clin Sci (Lond); 2008 Oct; 115(7):225-32. PubMed ID: 18307413
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inter-alpha-trypsin inhibitor heavy chain 4: a novel biomarker for environmental exposure to particulate air pollution in patients with chronic obstructive pulmonary disease.
    Lee KY; Feng PH; Ho SC; Chuang KJ; Chen TT; Su CL; Liu WT; Chuang HC
    Int J Chron Obstruct Pulmon Dis; 2015; 10():831-41. PubMed ID: 25977605
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distribution of clinical phenotypes in patients with chronic obstructive pulmonary disease caused by biomass and tobacco smoke.
    Golpe R; Sanjuán López P; Cano Jiménez E; Castro Añón O; Pérez de Llano LA
    Arch Bronconeumol; 2014 Aug; 50(8):318-24. PubMed ID: 24576449
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biomarkers of systemic inflammation in stable and exacerbation phases of COPD.
    Karadag F; Karul AB; Cildag O; Yilmaz M; Ozcan H
    Lung; 2008; 186(6):403-9. PubMed ID: 18807087
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Smoke, Biomass Exposure, and COPD Risk in the Primary Care Setting: The PUMA Study.
    Montes de Oca M; Zabert G; Moreno D; Laucho-Contreras ME; Lopez Varela MV; Surmont F
    Respir Care; 2017 Aug; 62(8):1058-1066. PubMed ID: 28559464
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FEV1 inversely correlates with metalloproteinases 1, 7, 9 and CRP in COPD by biomass smoke exposure.
    Montaño M; Sansores RH; Becerril C; Cisneros J; González-Avila G; Sommer B; Ochoa L; Herrera I; Ramírez-Venegas A; Ramos C
    Respir Res; 2014 Jun; 15(1):74. PubMed ID: 24980707
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased brachial intima-media thickness is associated with circulating levels of asymmetric dimethylarginine in patients with COPD.
    Urban MH; Eickhoff P; Funk GC; Burghuber OC; Wolzt M; Valipour A
    Int J Chron Obstruct Pulmon Dis; 2017; 12():169-176. PubMed ID: 28115840
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A gender difference in circulating neutrophils in malnourished patients with COPD.
    Larsson S; Nordenson A; Glader P; Yoshihara S; Lindén A; Slinde F
    Int J Chron Obstruct Pulmon Dis; 2011; 6():83-8. PubMed ID: 21407820
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interleukin-6 and interleukin-8 blood levels' poor association with the severity and clinical profile of ex-smokers with COPD.
    de Moraes MR; da Costa AC; Corrêa Kde S; Junqueira-Kipnis AP; Rabahi MF
    Int J Chron Obstruct Pulmon Dis; 2014; 9():735-43. PubMed ID: 25114519
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biomass smoke COPD has less tomographic abnormalities but worse hypoxemia compared with tobacco COPD.
    Meneghini AC; Koenigkam-Santos M; Pereira MC; Tonidandel PR; Terra-Filho J; Cunha FQ; Menezes MB; Vianna EO
    Braz J Med Biol Res; 2019; 52(5):e8233. PubMed ID: 31038579
    [TBL] [Abstract][Full Text] [Related]  

  • 34. COPD phenotypes in biomass smoke- versus tobacco smoke-exposed Mexican women.
    Camp PG; Ramirez-Venegas A; Sansores RH; Alva LF; McDougall JE; Sin DD; Paré PD; Müller NL; Silva CI; Rojas CE; Coxson HO
    Eur Respir J; 2014 Mar; 43(3):725-34. PubMed ID: 24114962
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Difference in systemic inflammation and predictors of acute exacerbation between smoking-associated COPD and tuberculosis-associated COPD.
    Oh JY; Lee YS; Min KH; Hur GY; Lee SY; Kang KH; Rhee CK; Park SJ; Shim JJ
    Int J Chron Obstruct Pulmon Dis; 2018; 13():3381-3387. PubMed ID: 30425468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk of acute exacerbations in chronic obstructive pulmonary disease associated with biomass smoke compared with tobacco smoke.
    Cho J; Lee CH; Hwang SS; Kim KU; Lee SH; Park HY; Park SJ; Min KH; Oh YM; Yoo KH; Jung KS;
    BMC Pulm Med; 2019 Mar; 19(1):68. PubMed ID: 30902075
    [TBL] [Abstract][Full Text] [Related]  

  • 37. FEV1 decline in patients with chronic obstructive pulmonary disease associated with biomass exposure.
    Ramírez-Venegas A; Sansores RH; Quintana-Carrillo RH; Velázquez-Uncal M; Hernandez-Zenteno RJ; Sánchez-Romero C; Velazquez-Montero A; Flores-Trujillo F
    Am J Respir Crit Care Med; 2014 Nov; 190(9):996-1002. PubMed ID: 25172140
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum Endostatin Is a Novel Marker for COPD Associated with Lower Lung Function, Exacerbation and Systemic Inflammation.
    Wu Y; Qin J; He J; Shen Y; Wang H; Li Y; Zeng Q; Dong J; An Y; Xiong S; Feng M; Wen F
    Int J Chron Obstruct Pulmon Dis; 2020; 15():397-407. PubMed ID: 32158205
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasminogen activator inhibitor-1 is elevated in patients with COPD independent of metabolic and cardiovascular function.
    Waschki B; Watz H; Holz O; Magnussen H; Olejnicka B; Welte T; Rabe KF; Janciauskiene S
    Int J Chron Obstruct Pulmon Dis; 2017; 12():981-987. PubMed ID: 28356730
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inverse association of plasma IL-13 and inflammatory chemokines with lung function impairment in stable COPD: a cross-sectional cohort study.
    Lee JS; Rosengart MR; Kondragunta V; Zhang Y; McMurray J; Branch RA; Choi AM; Sciurba FC
    Respir Res; 2007 Sep; 8(1):64. PubMed ID: 17868461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.